COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform
20/01/2026
FREDERICK, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced the sale of a Custom [...]
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
20/01/2026
FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review process Company expects to submit updates to the BLA in February 2026 to support continued FDA review SAN DIEGO, Jan. 20, 2026 (GLOBE [...]
New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems
20/01/2026
Survey finds nurse-first models help avoid three-quarters of unnecessary ED visits, are rated highly effective for reducing readmissions, and enhance patient outcomes through streamlined coordination Cincinnati, Jan. 20 [...]
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
20/01/2026
Peptinovo Biopharma’s Targeted Cancer Drug Platform Moves to Human Trials in Australia ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering [...]
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
20/01/2026
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to begin APTN-101, the Company’s Brain Bispecific T cell Engager (BRiTE), yields [...]
Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support
20/01/2026
Report Emphasises the Importance of Home Support in Alleviating Hospital Pressures and Supporting Aging Population Dublin, Ireland, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Comfort Keepers Ireland , a leading homecare provider [...]
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
20/01/2026
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA’s Fast Track designation for ateganosine in NSCLC advances [...]
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
20/01/2026
Company implements next growth stage following successful strategic and operational development Uwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed interim CEO LAUPHEIM, Germany and MILFORD, Mass., Jan [...]
Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
20/01/2026
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orphai Therapeutics Inc. (“Orphai”) , a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant [...]
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced continued operational growth [...]
Vitalic Health, powered by HFMA, launches U.S. Healthcare Vitals Tracker to measure affordability, financial sustainability and health outcomes
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association’s Vitalic Health today released the U.S. Vitals Tracker, a first-of-its-kind tool that measures the health of U.S. healthcare. [...]
Next-Generation Healthcare Provider ONTO Health Names Dr. Roohi Jeelani Founder & CEO, Expands to Chicago and the Midwest
20/01/2026
ONTO Health is advancing a more comprehensive, human-centered approach to healthcare, supporting health and well-being across the lifespan Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ONTO Health , a next-generation [...]
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
20/01/2026
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody [...]
New Research Reveals Key Quality of Life Insights in ADHD Management
20/01/2026
Qbtech research analyzing nearly 1,000 patients found a correlation between objective ADHD performance and meaningful changes in daily functioning and well-being HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech , a [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
20/01/2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 20 janvier 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF et annonce de sa suspension
20/01/2026
Titre concerné : CARBIOS (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 20 janvier 2026 (18h00 CET). CARBIOS présente le bilan semestriel du contrat de liquidité conclu [...]
CARBIOS : half-year report on the liquidity contract entrusted to Natixis ODDO BHF and notice of suspension
20/01/2026
PRESS RELEASE Shares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth Paris Clermont-Ferrand, France, January 20, 2026 (6:00 pm CET). CARBIOS today presents the half-year report on the [...]
Bilan semestriel du contrat de liquidité avec Invest Securities
20/01/2026
Bilan semestriel du contrat de liquidité avec Invest Securities Nantes, le 20 janvier 2026, 18 heures – Au titre du contrat de liquidité confié par OSE Immunotherapeutics à Invest Securities, les moyens suivants [...]
Half-Year Report on Liquidity Contract with Invest Securities
20/01/2026
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France - January 20, 2026, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following [...]

Pages